🚀 VC round data is live in beta, check it out!
Kyowa Kirin Valuation Multiples
Discover revenue and EBITDA valuation multiples for Kyowa Kirin and similar public comparables like Praxis Precision Medicines, Fosun Pharma, Abivax, Huadong Medicine and more.
Kyowa Kirin Overview
About Kyowa Kirin
Kyowa Kirin Co Ltd is engaged in research, development, manufacturing, sales, import and export of prescription pharmaceuticals. Its products include KHK4083/AMG 451, rocatinlimab; ziftomenib; OTL-203 KK8398, infigratinib; KHK4951, tivozanib; OTL-201; KK4277; KK2260; KK2269; KK2845; and KK8123.
Founded
1949
HQ
Employees
5.7K
Website
Sectors
Financials (LTM)
EV
$8B
Kyowa Kirin Financials
Kyowa Kirin reported last 12-month revenue of $3B and EBITDA of $843M.
In the same LTM period, Kyowa Kirin generated $2B in gross profit, $843M in EBITDA, and $446M in net income.
Revenue (LTM)
Kyowa Kirin P&L
In the most recent fiscal year, Kyowa Kirin reported revenue of $3B and EBITDA of $735M.
Kyowa Kirin expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Margin | 74% | XXX | 73% | XXX | XXX | XXX |
| EBITDA | $843M | XXX | $735M | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | 23% | XXX | XXX | XXX |
| EBIT Margin | 21% | XXX | 19% | XXX | XXX | XXX |
| Net Profit | $446M | XXX | $380M | XXX | XXX | XXX |
| Net Margin | 14% | XXX | 12% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Kyowa Kirin Stock Performance
Kyowa Kirin has current market cap of $9B, and enterprise value of $8B.
Market Cap Evolution
Kyowa Kirin's stock price is $17.82.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8B | $9B | (0.4%) | XXX | XXX | XXX | $0.73 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialKyowa Kirin Valuation Multiples
Kyowa Kirin trades at 2.5x EV/Revenue multiple, and 9.4x EV/EBITDA.
EV / Revenue (LTM)
Kyowa Kirin Financial Valuation Multiples
As of March 7, 2026, Kyowa Kirin has market cap of $9B and EV of $8B.
Equity research analysts estimate Kyowa Kirin's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Kyowa Kirin has a P/E ratio of 20.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $9B | XXX | $9B | XXX | XXX | XXX |
| EV (current) | $8B | XXX | $8B | XXX | XXX | XXX |
| EV/Revenue | 2.5x | XXX | 2.5x | XXX | XXX | XXX |
| EV/EBITDA | 9.4x | XXX | 10.8x | XXX | XXX | XXX |
| EV/EBIT | 11.9x | XXX | 13.6x | XXX | XXX | XXX |
| EV/Gross Profit | 3.3x | XXX | 3.4x | XXX | XXX | XXX |
| P/E | 20.9x | XXX | 24.5x | XXX | XXX | XXX |
| EV/FCF | 82.9x | XXX | (33.4x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Kyowa Kirin Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Kyowa Kirin Margins & Growth Rates
Kyowa Kirin's revenue in the last 12 month grew by 2%.
Kyowa Kirin's revenue per employee in the last FY averaged $0.6M.
Kyowa Kirin's rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Kyowa Kirin's rule of X is 31% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Kyowa Kirin Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | 23% | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | 14% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 28% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 31% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 34% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 21% | XXX | 21% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 55% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Kyowa Kirin Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Praxis Precision Medicines | XXX | XXX | XXX | XXX | XXX | XXX |
| Fosun Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Abivax | XXX | XXX | XXX | XXX | XXX | XXX |
| Huadong Medicine | XXX | XXX | XXX | XXX | XXX | XXX |
| Eisai Co. | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Kyowa Kirin M&A Activity
Kyowa Kirin acquired XXX companies to date.
Last acquisition by Kyowa Kirin was on XXXXXXXX, XXXXX. Kyowa Kirin acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Kyowa Kirin
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialKyowa Kirin Investment Activity
Kyowa Kirin invested in XXX companies to date.
Kyowa Kirin made its latest investment on XXXXXXXX, XXXXX. Kyowa Kirin invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Kyowa Kirin
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Kyowa Kirin
| When was Kyowa Kirin founded? | Kyowa Kirin was founded in 1949. |
| Where is Kyowa Kirin headquartered? | Kyowa Kirin is headquartered in Japan. |
| How many employees does Kyowa Kirin have? | As of today, Kyowa Kirin has over 5K employees. |
| Who is the CEO of Kyowa Kirin? | Kyowa Kirin's CEO is Masashi Miyamoto. |
| Is Kyowa Kirin publicly listed? | Yes, Kyowa Kirin is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Kyowa Kirin? | Kyowa Kirin trades under 4151 ticker. |
| When did Kyowa Kirin go public? | Kyowa Kirin went public in 1949. |
| Who are competitors of Kyowa Kirin? | Kyowa Kirin main competitors are Praxis Precision Medicines, Fosun Pharma, Abivax, Huadong Medicine. |
| What is the current market cap of Kyowa Kirin? | Kyowa Kirin's current market cap is $9B. |
| What is the current revenue of Kyowa Kirin? | Kyowa Kirin's last 12 months revenue is $3B. |
| What is the current revenue growth of Kyowa Kirin? | Kyowa Kirin revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Kyowa Kirin? | Current revenue multiple of Kyowa Kirin is 2.5x. |
| Is Kyowa Kirin profitable? | Yes, Kyowa Kirin is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Kyowa Kirin? | Kyowa Kirin's last 12 months EBITDA is $843M. |
| What is Kyowa Kirin's EBITDA margin? | Kyowa Kirin's last 12 months EBITDA margin is 26%. |
| What is the current EV/EBITDA multiple of Kyowa Kirin? | Current EBITDA multiple of Kyowa Kirin is 9.4x. |
| What is the current FCF of Kyowa Kirin? | Kyowa Kirin's last 12 months FCF is $96M. |
| What is Kyowa Kirin's FCF margin? | Kyowa Kirin's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Kyowa Kirin? | Current FCF multiple of Kyowa Kirin is 82.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.